# The UK ICGC Prostate Cancer Analysis Network

## The Project

The Cancer Research UK funded Prostate [ICGC](icgc.org) project was [launched in 2011](https://ukicgcprostateanalysts.github.io/) with a view to analysing the genomes of 250 cancerous prostates in order to learn more about the molecular contribution to, and biomarkers of, the severity of the disease as well as adding to our knowledge of the biology and characterization of prostate cancer. Led out of The Royal Marsden, and ICR, the project was, from the outset, a collaboration between clinicians, biologists, pathologists and analysts (statisticians, epidemiologists, bioinformaticians, computational biologists etc.). Subsequent iterations of the project have seen more complex data sets being generated for the study cohort, with a corresponding increase in the complexity of required analyses. The project is part of several ecosystems of cancer sequencing projects including [The PanProstate Cancer Group](http://panprostate.org/) and [ICGC-ARGO](https://www.icgc-argo.org/).

## The Analysis Network

Over the lifetime of the project, there have naturally been changes within the analysis group, but the institutions currently involved include

* The University of East Anglia
* The Welcome Trust Sanger Centre
* The Institute of Cancer Research
* The University of St Andrews
* The University of Cambridge
* The University of Manchester
* The University of Oxford

## Support

Since 2023, the network has been supported by an Isaac Newton Institute network grant funded through the EPSRC.

## Outputs

The analysts in this network have contributed to several papers using data from the Cancer Research UK funded Prostate [ICGC](icgc.org) project including.

* Burns D, Anokian E, Saunders EJ, Bristow RG, Fraser M, Reimand J, Schlomm T, Sauter G, Brors B, Korbel J, Weischenfeldt J, Waszak SM, Corcoran NM, Jung CH, Pope BJ, Hovens CM, Cancel-Tassin G, Cussenot O, Loda M, Sander C, Hayes VM, Dalsgaard Sorensen K, Lu YJ, Hamdy FC, Foster CS, Gnanapragasam V, Butler A, Lynch AG, Massie CE; CR-UK/Prostate Cancer UK, ICGC, The PPCG, Woodcock DJ, Cooper CS, Wedge DC, Brewer DS, Kote-Jarai Z, Eeles RA. (2022) "[Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study](https://pubmed.ncbi.nlm.nih.gov/35659150/)" *Eur Urol.* **82** 201-211
* Hurst R, Meader E, Gihawi A, Rallapalli G, Clark J, Kay GL, Webb M, Manley K, Curley H, Walker H, Kumar R, Schmidt K, Crossman L, Eeles RA, Wedge DC, Lynch AG, Massie CE; CRUK-ICGC Prostate Group, Yazbek-Hanna M, Rochester M, Mills RD, Mithen RF, Traka MH, Ball RY, O'Grady J, Brewer DS, Wain J, Cooper CS. (2022) "[Microbiomes of Urine and the Prostate Are Linked to Human Prostate Cancer Risk Groups](https://pubmed.ncbi.nlm.nih.gov/35450835/)" *Eur Urol Oncol.*  **5** 412-419
* Wedge DC, Gundem G, Mitchell T, Woodcock DJ, Martincorena I, Ghori M, Zamora J, Butler A, Whitaker H, Kote-Jarai Z, Alexandrov LB, Van Loo P, Massie CE, Dentro S, Warren AY, Verrill C, Berney DM, Dennis N, Merson S, Hawkins S, Howat W, Lu YJ, Lambert A, Kay J, Kremeyer B, Karaszi K, Luxton H, Camacho N, Marsden L, Edwards S, Matthews L, Bo V, Leongamornlert D, McLaren S, Ng A, Yu Y, Zhang H, Dadaev T, Thomas S, Easton DF, Ahmed M, Bancroft E, Fisher C, Livni N, Nicol D, Tavaré S, Gill P, Greenman C, Khoo V, Van As N, Kumar P, Ogden C, Cahill D, Thompson A, Mayer E, Rowe E, Dudderidge T, Gnanapragasam V, Shah NC, Raine K, Jones D, Menzies A, Stebbings L, Teague J, Hazell S, Corbishley C; CAMCAP Study Group, de Bono J, Attard G, Isaacs W, Visakorpi T, Fraser M, Boutros PC, Bristow RG, Workman P, Sander C; TCGA Consortium, Hamdy FC, Futreal A, McDermott U, Al-Lazikani B, Lynch AG, Bova GS, Foster CS, Brewer DS, Neal DE, Cooper CS, Eeles RA (2018) "[Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets](https://pubmed.ncbi.nlm.nih.gov/29662167/)" *Nature Genetics* **50** 682–692
* Camacho N., Van Loo P., Edwards S., Kay J.D., Matthews L., Haase K., Clark J., Dennis N., Thomas S., Kremeyer B., Zamora J., Butler A.P., Gundem G., Merson S., Luxton H., Hawkins S., Ghori M., Marsden L., Lambert A., Karaszi K., Pelvender G., Massie C. E., Kote-Jarai Z., Raine K., Jones D., Howat W. J., Hazell S., Livni N., Fisher C., Ogden C., Kumar P., Thompson A., Nicol D., Mayer E., Dudderidge T., Yu Y., Zhang H., Shah N. C., Gnanapragasam V. J., The CRUK-ICGC Prostate Group, Isaacs W., Visakorpi T., Hamdy F., Berney D., Verrill C., Warren A. Y., Wedge D. C., Lynch A.G., Foster C. S., Lu Y. J., Bova G. S., Whitaker H. C., McDermott U., Neal D. E., Eeles R., Cooper C. S. and Brewer D. S. (2017) "[Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data](https://pubmed.ncbi.nlm.nih.gov/28945760/)" *PLoS Genetics* **13**(9): e1007001
* Behjati S, Gundem G, Wedge DC, Roberts ND, Tarpey PS, Cooke SL, Van Loo P, Alexandrov LB, Ramakrishna M, Davies H, Nik-Zainal S, Hardy C, Latimer C, Raine KM, Stebbings L, Menzies A, Jones D, Shepherd R, Butler AP, Teague JW, Jorgensen M, Khatri B, Pillay N, Shlien A, Futreal PA, Badie C, ICGC Prostate Group, McDermott U, Bova GS, Richardson AL, Flanagan AM, Stratton MR and Campbell PJ (2016) "[Mutational signatures of ionizing radiation in second malignancies](https://pubmed.ncbi.nlm.nih.gov/27615322/)" *Nature Communications* **7**, Article number: 12605
* Cooper C, Eeles R, Wedge DC, Loo PV, Gundem G, Alexandrov LB, Kremeyer B, Butler AP, Lynch AG, Camacho N, Massie CE, Kay JD, Luxton HJ, Edwards S, Kote-Jarai Z, Dennis N, Merson S, Leongamornlert D, Zamora J, Corbishley C, Thomas S, Nik-Zainal S, O’Meara S, Matthews L, Clark J, Hurst R, Mithen R, Bristow RG, Boutros PC, Fraser M, Cooke S, Raine K, Jones D, Menzies A, Stebbings L, Hinton J, Teague J, McLaren S, Mudie L, Hardy C, Anderson E, Joseph O, Goody V, Robinson B, Maddison M, Gamble SJ, Greenman C, Berney D, Hazell S, Livni N, The ICGC Prostate Group, Fisher C, Ogden C, Kumar P, Thompson A, Woodhouse C, Nicol D, Mayer E, Dudderidge T, Shah NC, Gnanapragasam VJ, Voet T, Campbell PJ, Futreal A, Easton D, Warren AY, Foster CS, Stratton MR, Whitaker HC, McDermott U, Brewer D and Neal DE. (2015) "[Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue](https://pubmed.ncbi.nlm.nih.gov/25730763/)" *Nature Genetics* **47**, 367–372
* Massie CE, Spiteri I, Ross-Adams H, Luxton H, Kay J, Whitaker HC, Dunning MJ, Lamb AD, Ramos-Montoya A, Brewer DS, Cooper CS, Eeles R, UK Prostate ICGC Group, Warren A, Tavaré S, Neal DE and Lynch AG. (2015) “[HES5 silencing is an early and recurrent change in prostate tumourigenesis](https://pubmed.ncbi.nlm.nih.gov/25560400/)” *Endocrine-related Cancer* **22**, 131-144
* Gundem G, Van Loo P, Kremeyer B, Alexandrov LB, Tubio JMC, Papaemmanuil E, Brewer DS, Kallio HML, Högnäs G, Annala M, Kivinummi K, Goody V, Latimer C, O'Meara S, Dawson KJ, Isaacs W, Emmert-Buck MR, Nykter M, Foster C, Kote-Jarai Z, Easton D, Whitaker HC, ICGC Prostate UK Group, Neal DE, Cooper CS, Eeles RA, Visakorpi T, Campbell PJ, McDermott U, Wedge DC and Bova GS (2015) "[The evolutionary history of lethal metastatic prostate cancer](https://pubmed.ncbi.nlm.nih.gov/25830880/)" *Nature* **520**, 353–357
* Ju YS, Alexandrov LB, Gerstung M, Martincorena I, Nik-Zainal S, Ramakrishna M, Davies HR, Papaemmanuil E, Gundem G,  Shlien A, Bolli N, Behjati S, Tarpey PS, Nangalia J, Massie CE, Butler AP, Teague JW, Vassiliou GS, Green AR, Du M-Q, Unnikrishnan A, Pimanda JE, Teh BT, Munshi N, Greaves M, Vyas P, El-Naggar AK, Santarius T, Collins VP, Grundy R, Taylor JA, Hayes DN, Malkin D, ICGC Breast Cancer Group, ICGC Chronic Myeloid Disorders Group, ICGC Prostate Cancer Group, Foster C, Warren AY, Whitaker H, Brewer D, Eeles R, Cooper C, Neal D, Visakorpi T, Isaacs WB, Bova GS, Flanagan AM, Futreal PA, Lynch AG, Chinnery PF, McDermott U, Stratton MR and Campbell PJ. (2014) "[Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer](https://pubmed.ncbi.nlm.nih.gov/25271376/)" *eLife* 10.7554/eLife.02935
*Tubio JMC, Li Y, Ju YS, Martincorena I, Cooke SL, Tojo M, Gundem G, Pipinikas CP, Zamora J, Raine K, Menzies A, Roman-Garcia P, Fulham A, Gerstung M, Shlien A, Tarpey PS, Papaemmanuil E, Knappskog S, Van Loo P, Ramakrishna M, Davies HR, Marshall J, Wedge DC, Teague JW, Butler AP, Nik-Zainal S, Alexandrov L, Behjati S, Yates LR, Bolli N, Mudie L, Hardy C, Martin S, McLaren S, O'Meara S, Anderson E, Maddison M, Gamble S, ICGC Breast Cancer Group, ICGC Bone Cancer Group, ICGC Prostate Cancer Group, Foster C, Warren AY, Whitaker H, Brewer D, Eeles R, Cooper C, Neal D, Lynch AG, Visakorpi T, Isaacs WB, van 't Veer L, Caldas C, Desmedt C, Sotiriou C, Aparicio S, Foekens J, Eyfjörd JE, Lakhani SR, Thomas G, Myklebost O, Span PN, Børresen-Dale A-L, Richardson AL, Van de Vijver M, Vincent-Salomon A, Van den Eynden GG, Flanagan AM, Futreal PA, Janes SM, Bova GS, Stratton MR, McDermott U and Campbell PJ. (2014) "[Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes](https://pubmed.ncbi.nlm.nih.gov/25082706/)" *Science* **345**, DOI:10.1126/science.1251343
